B. J. Goldstein

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Faiyaz Ahmad, J. L. Azevedo, Ronald Cortright et al. · Journal of Clinical Investigation · 1997 · 288 citations · Full text

Life Sciences, Biochemistry, Physiology +17

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double‐blind, non‐inferiority trial

Rosario Arechavaleta, Thomas Seck, Karl J. Krobot et al. · Diabetes Obesity and Metabolism · 2010 · 164 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

Pablo Aschner, H. L. Katzeff, Hongquan Guo et al. · Diabetes Obesity and Metabolism · 2009 · 156 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

Debora Williams‐Herman, J. Johnson, R. Teng et al. · Diabetes Obesity and Metabolism · 2010 · 153 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.

Faiyaz Ahmad, Robert V. Considine, B. J. Goldstein · Journal of Clinical Investigation · 1995 · 126 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17